Harm Reduction in Charm City
The backlash against harm reduction ignores success in Baltimore, Maryland.
Psychedelic Drugs Going Mainstream
Drug maker Eli Lilly recently purchased psychedelic drug manufacturer, AtaiBeckley, signaling a new interest in psychedelic drugs.
Reward Theory vs. Relief Theory
The reward theory of addiction puts the emphasis on the substance rather than the stress.
Psychorphine? Monster New Drugs Hitting U.S. Market
New synthetic opioids cychlorphine and nitazines are 10 times worse than fentanyl, and they’re headed this way.
A New Source of Ibogaine
Researchers in Brazil have discovered a new source of ibogaine that can be harvested with less environmental damage.
National Drug Control Strategy Is Strong on Supply, Weak on Demand
The newly-released National Drug Control Policy is heavy on law enforcement and light on addiction treatment.